0001181431-13-015379.txt : 20130307 0001181431-13-015379.hdr.sgml : 20130307 20130307165022 ACCESSION NUMBER: 0001181431-13-015379 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YACHMETZ PHILIP K CENTRAL INDEX KEY: 0001250318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13673999 MAIL ADDRESS: STREET 1: 501 LAFAYETTE AVE CITY: WYCKOFF STATE: NJ ZIP: 07481 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd373175.xml YACHMETZ FORM 4 X0306 4 2013-03-05 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001250318 YACHMETZ PHILIP K SAVIENT PHARMACEUTICALS, INC. 400 CROSSING BLVD. BRIDGEWATER NJ 08807 0 1 0 0 SVP, General Counsel Option to Purchase Common Stock 0.94 2013-03-05 4 A 0 110000 0 A 2023-03-05 Common Stock 110000 110000 D Option to Purchase Common Stock 2.26 2013-03-05 4 A 0 78000 0 A 2022-02-01 Common Stock 78000 78000 D These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013. These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012. Philip K. Yachmetz 2013-03-07